e-Drug3D

1207

NOREPINEPHRINE


INN
NOREPINEPHRINE

(is an active metabolite)

cas 51-41-2
CLASS

CARDIOVASCULAR
ADRENERGIC RECEPTOR AGONIST
SYMPATHOMIMETICS
VASOCONSTRICTOR AGENTS
PERIPHERAL VASOCONSTRICTOR (ALPHA-ADRENERGIC ACTION) AND AS AN INOTROPIC STIMULATOR OF THE HEART AND DILATOR OF CORONARY ARTERIES (BETA-ADRENERGIC ACTION)

ROUTE (list)

INJECTION INTRAVENOUS

NATURAL MOLECULE (link)

ATC code

C01CA03

PK parameters

Solubility

SPARINGLY SOLUBLE IN WATER


Target

TARGET ADRENERGIC RECEPTORS

PDB
3HCD (CRYSTAL STRUCTURE OF HPNMT IN COMPLEX WITH NORADRENALINE AND ADOHCY)

Ligand code = LNR (link to the list of PDB complexes)

Download experimental 3D coordinates of LNR with added hydrogens

DrugCentral

Beta-1 adrenergic receptor UNIPROT P08588 ADRB1

Beta-2 adrenergic receptor UNIPROT P07550 ADRB2

Download SDF file 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol

Formula:
C8H11NO3

Calculated chemical properties:

MW 169.18
NB_atoms 12
XLogP 0.09
PSA 87.389
NB_HD 5
NB_HA 4
fsp3 0.25
Lipinski(0=no;1=yes) 1

FDA
NDA 007513 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) LEVOPHED (HOSPIRA) APPROVAL= AP YEAR= 1950
NDA 008592 (pdf not found) INN (NOREPINEPHRINE BITARTRATE ; PROCAINE HYDROCHLORIDE ; PROPOXYCAINE HYDROCHLORIDE) RAVOCAINE AND NOVOCAIN W/ LEVOPHED (EASTMAN KODAK) APPROVAL= AP YEAR= 1952 DISCONTINUED
NDA 040455 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (MEITHEAL) APPROVAL= AP YEAR= 2003
NDA 040462 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (HIKMA) APPROVAL= AP YEAR= 2003
NDA 040522 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (METRICS PHARM) APPROVAL= AP YEAR= 2004 DISCONTINUED
NDA 040859 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2012
NDA 203662 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (HIKMA) APPROVAL= AP YEAR= 2018
NDA 210839 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (AMNEAL) APPROVAL= AP YEAR= 2018
NDA 211242 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (MYLAN LABS LTD) APPROVAL= AP YEAR= 2018
NDA 211359 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (SANDOZ) APPROVAL= AP YEAR= 2018
NDA 211382 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2020
NDA 211980 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (SUN PHARM) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 214313 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2021
NDA 214323 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (GLAND) APPROVAL= AP YEAR= 2021
NDA 214455 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BRECKENRIDGE) APPROVAL= AP YEAR= 2021
NDA 214628 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (LONG GROVE PHARMS) APPROVAL= AP YEAR= 2022
NDA 215700 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (INFORLIFE) APPROVAL= AP YEAR= 2022
NDA 216341 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2022 DISCONTINUED
NDA 217575 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (CAPLIN) APPROVAL= AP YEAR= 2023
NDA 218758 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (RISING) APPROVAL= AP YEAR= 2024
NDA 219163 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (ASPIRO) APPROVAL= AP YEAR= 2025
NDA 219443 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BIOCON PHARMA) APPROVAL= AP YEAR= 2025
NDA 219692 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (SAGENT) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL